These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31190683)

  • 21. Host-Salmonella interaction: human trials.
    Levine MM; Tacket CO; Sztein MB
    Microbes Infect; 2001; 3(14-15):1271-9. PubMed ID: 11755415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Salmonella typhi Vi conjugate vaccine.
    Koul PA
    N Engl J Med; 2001 Aug; 345(7):545-6. PubMed ID: 11519517
    [No Abstract]   [Full Text] [Related]  

  • 23. Formative investigation of acceptability of typhoid vaccine during a typhoid fever outbreak in Neno District, Malawi.
    Blum LS; Dentz H; Chingoli F; Chilima B; Warne T; Lee C; Hyde T; Gindler J; Sejvar J; Mintz ED
    Am J Trop Med Hyg; 2014 Oct; 91(4):729-37. PubMed ID: 25002303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Typhoid Conjugate Vaccines: Advancing the Research and Public Health Agendas.
    Birkhold M; Mwisongo A; Pollard AJ; Neuzil KM
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S781-S787. PubMed ID: 34528085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Typhoid fever & vaccine development: a partially answered question.
    Marathe SA; Lahiri A; Negi VD; Chakravortty D
    Indian J Med Res; 2012; 135(2):161-9. PubMed ID: 22446857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccines for preventing typhoid fever.
    Anwar E; Goldberg E; Fraser A; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001261. PubMed ID: 24385413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in vaccines for typhoid fever.
    Gupta A; Jalla S; Sazawal S; Bhan MK
    Indian J Pediatr; 1994; 61(4):321-39. PubMed ID: 8002060
    [No Abstract]   [Full Text] [Related]  

  • 28. Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials.
    Fraser A; Paul M; Goldberg E; Acosta CJ; Leibovici L
    Vaccine; 2007 Nov; 25(45):7848-57. PubMed ID: 17928109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient vaccination strategy against typhoid fever.
    Arya SC
    Vaccine; 2000 May; 18(22):2321-2. PubMed ID: 10905949
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children.
    Patel PD; Patel P; Liang Y; Meiring JE; Misiri T; Mwakiseghile F; Tracy JK; Masesa C; Msuku H; Banda D; Mbewe M; Henrion M; Adetunji F; Simiyu K; Rotrosen E; Birkhold M; Nampota N; Nyirenda OM; Kotloff K; Gmeiner M; Dube Q; Kawalazira G; Laurens MB; Heyderman RS; Gordon MA; Neuzil KM;
    N Engl J Med; 2021 Sep; 385(12):1104-1115. PubMed ID: 34525285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generating the Evidence for Typhoid Vaccine Introduction: Considerations for Global Disease Burden Estimates and Vaccine Testing Through Human Challenge.
    Meiring JE; Giubilini A; Savulescu J; Pitzer VE; Pollard AJ
    Clin Infect Dis; 2019 Oct; 69(Suppl 5):S402-S407. PubMed ID: 31612941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Vi polysaccharide vaccine against strains of Salmonella typhi: reply.
    Keddy KH; Klugman KP; Robbins JB
    Vaccine; 1998; 16(9-10):871-2. PubMed ID: 9682329
    [No Abstract]   [Full Text] [Related]  

  • 34. New advances in typhoid Fever vaccination strategies.
    Bhutta ZA; Khan MI; Soofi SB; Ochiai RL
    Adv Exp Med Biol; 2011; 697():17-39. PubMed ID: 21120717
    [No Abstract]   [Full Text] [Related]  

  • 35. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.
    Mai NL; Phan VB; Vo AH; Tran CT; Lin FY; Bryla DA; Chu C; Schiloach J; Robbins JB; Schneerson R; Szu SC
    N Engl J Med; 2003 Oct; 349(14):1390-1. PubMed ID: 14523155
    [No Abstract]   [Full Text] [Related]  

  • 37. [Vaccination against typhoid fever: results and perspectives].
    Gremiakova TA; Fursova NK; Stepanov AV
    Vestn Ross Akad Med Nauk; 1997; (6):11-6. PubMed ID: 9289271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enteric Fever and Invasive Nontyphoidal Salmonellosis--9th International Conference on Typhoid and Invasive NTS Disease, Bali, Indonesia, April 30-May 3, 2015.
    Khan MI; Katrinak C; Freeman A; Franco-Paredes C
    Emerg Infect Dis; 2016 Apr; 22(4):. PubMed ID: 27366797
    [No Abstract]   [Full Text] [Related]  

  • 39. Re-infection of typhoid fever and typhoid vaccine (comment on "An imported enteric fever caused by a quinolone-resistant Salmonella typhi").
    Zaki S
    Ann Saudi Med; 2011; 31(2):203-4; author reply 204. PubMed ID: 21403404
    [No Abstract]   [Full Text] [Related]  

  • 40. Community Engagement Before Initiation of Typhoid Conjugate Vaccine Trial in Schools in Two Urban Townships in Blantyre, Malawi: Experience and Lessons.
    Meiring JE; Sambakunsi R; Moyo E; Misiri T; Mwakiseghile F; Patel P; Patel P; Ndaferankhande J; Laurens M; Gooding K; Gordon MA
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S146-S153. PubMed ID: 30845322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.